Resveratrol and endothelial function: A literature review

• Published in: Pharmacological research 2021-08, Vol.170, p.105725-105725, Article 105725
• Main Authors: Parsamanesh, Negin, Asghari, Arghavan, Sardari, Saeed, Tasbandi, Aida, Jamialahmadi, Tannaz, Xu, Suowen, Sahebkar, Amirhossein
• Format: Article
• Language: English
• Subjects: Angiogenesis Inhibitors - pharmacology; Animals; Antihypertensive Agents - pharmacology; Cardiovascular Agents - pharmacology; Cardiovascular disease; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - metabolism; Cardiovascular Diseases - pathology; Cardiovascular Diseases - physiopathology; Endothelial Cells - drug effects; Endothelial Cells - metabolism; Endothelial Cells - pathology; Endothelial dysfunction; Endothelial function; Endothelium, Vascular - drug effects; Endothelium, Vascular - metabolism; Endothelium, Vascular - pathology; Endothelium, Vascular - physiopathology; Fibrinolytic Agents - pharmacology; Humans; Hypoglycemic Agents - pharmacology; Resveratrol; Resveratrol - pharmacology; Signal Transduction; Therapeutic targets
• ISSN: 1043-6618; 1096-1186
• DOI: 10.1016/j.phrs.2021.105725

Endothelial dysfunction is a major contributing factor to diseases such as atherosclerosis, diabetes mellitus, obesity, hypertension, acute lung injury, preeclampsia, among others. Resveratrol (RSV) is a naturally occurring bioactive polyphenol found in grapes and red wine. According to experimental studies, RSV modulates several events involved in endothelial dysfunction such as impaired vasorelaxation, eNOS uncoupling, leukocyte adhesion, endothelial senescence, and endothelial mesenchymal transition. The endothelial protective effects of RSV are found to be mediated by numerous molecular targets (e.g. Silent Information Regulator 1 (SIRT1), 5′ AMP-activated protein kinase (AMPK), endothelial nitric oxide synthase (eNOS), nuclear factor-erythroid-derived 2-related factor-2 (Nrf2), peroxisome proliferator-activated receptor (PPAR), Krüppel-like factor-2 (KLF2), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB)). Herein, we present an updated review addressing pharmacological effects and molecular targets of RSV in maintaining endothelial function, and the potential of this phytochemical for endothelial dysfunction-associated disorders. [Display omitted]